Publication

Article

BioPharm International

BioPharm International-10-01-2001
Volume14
Issue 10

Inside Washington: Crisis and Costs Grip Biotech Industry

Author(s):

by Jill Wechsler Terrorist attack may postpone health policy legislation but encourage antibioterrorism initiatives.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, CSO, AustinPx
© 2025 MJH Life Sciences

All rights reserved.